Diplomat Pharmacy, Inc. (NYSE:DPLO) Upgraded to C- at TheStreet

Xavier Trudeau
Août 13, 2017

State Board Of Administration Of Florida Retirement Systems accumulated 0% or 23,902 shares. Dimensional Fund Advisors LP now owns 303,696 shares of the company's stock valued at $3,827,000 after buying an additional 11,902 shares during the last quarter. Morgan Stanley now has $86.94 billion valuation. Envestnet Asset Mngmt holds 0% or 8,665 shares. It is down 4.11% since August 11, 2016 and is downtrending. It has outperformed by 7.35% the S&P500.

Friedberg Investment Management decreased Diplomat Pharmacy (DPLO) stake by 63.2% reported in 2016Q4 SEC filing. The correct version of this story can be viewed at https://stocknewstimes.com/2017/08/11/diplomat-pharmacy-inc-nysedplo-rating-increased-to-hold-at-zacks-investment-research.html. Diplomat Pharmacy, Inc. (DPLO) has made its way to a 12-month decline of -54.98%. The stock increased 0.06% or $0.02 during the last trading session, reaching $32.45. Needham & Company LLC started coverage on shares of Diplomat Pharmacy in a report on Friday, July 21st.

Diplomat Pharmacy (NYSE:DPLO) last released its quarterly earnings data on Monday, August 7th. It has underperformed by 57.18% the S&P500. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company's stock. Aquinox Pharma had 7 analyst reports since September 11, 2015 according to SRatingsIntel. Leerink Swann maintained the stock with "Outperform" rating in Tuesday, August 4 report. The firm has "Strong-Buy" rating given on Friday, April 21 by Vining Sparks. The firm has "Mkt Perform" rating given on Thursday, November 3 by Leerink Swann. UBS has "Buy" rating and $35 target. As per Monday, June 12, the company rating was maintained by Bernstein. The firm has "Outperform" rating given on Wednesday, May 18 by Howard Weil. The stock has "Hold" rating by Sandler O'Neill on Thursday, October 6.

Since February 21, 2017, it had 0 insider purchases, and 2 insider sales for $1.53 million activity. 13,000 shares were sold by Jennings Michael, worth $369,200. Janney Montgomery Scott LLC bought a new position in shares of Diplomat Pharmacy during the first quarter worth about $160,000. It also reduced Spdr S&P 500 Etf Tr (SPY) stake by 13,186 shares and now owns 152,318 shares. Freeport Mcmoran (NYSE:FCX) was reduced too. 143.45 million shares or 0.74% less from 144.52 million shares in 2016Q3 were reported. Comerica Retail Bank owns 46,130 shares for 0.01% of their portfolio. Morgan Stanley reported 559,311 shares. The stock's market capitalization is 1.11B. Convergence Prtn Limited Liability Com accumulated 0.19% or 41,586 shares. Moreover, Caisse De Depot Et Placement Du Quebec has 0.01% invested in HollyFrontier Corp (NYSE:HFC).

FMC Corporation (NYSE:FMC) tinted loss of -0.27% (-0.23 points) to US$84.37. Royal Bank Of Canada holds 14,570 shares. Barclays PLC set a $20.00 target price on Diplomat Pharmacy and gave the company a "buy" rating in a research report on Tuesday, May 9th. Therefore 33% are positive. NY's holdings in Diplomat Pharmacy were worth $511,000 at the end of the most recent reporting period. Finally, Zacks Investment Research downgraded shares of Diplomat Pharmacy from a "hold" rating to a "sell" rating in a research note on Monday, July 17th. Mizuho has "Neutral" rating and $17 target. The company was maintained on Wednesday, May 11 by Mizuho. Aquinox Pharma has $25 highest and $9 lowest target. The firm has "Buy" rating by Robert W. Baird given on Tuesday, August 8.

As of quarter end Ameriprise Financial Inc had acquired 690 shares growing its stake by 40.7%.

Investors sentiment increased to 1.15 in 2016 Q4. Its down 0.88, from 1.82 in 2016Q3. It is positive, as 53 investors sold MS shares while 267 reduced holdings. 123 funds opened positions while 723 raised stakes.

As analysts monitor volatile markets in recent weeks they have updated their price targets on shares of Diplomat Pharmacy, Inc. Diplomat Pharmacy has a 52 week low of $12.25 and a 52 week high of $34.80. Alliancebernstein Ltd Partnership holds 0% or 73,030 shares. Diplomat Pharmacy had a return on equity of 7.97% and a net margin of 0.27%. 314,277 were reported by Principal Financial Group Incorporated. On average, analysts expect that Diplomat Pharmacy, Inc. will post $0.75 EPS for the current fiscal year.

Weatherbie Capital Llc decreased Aerie Pharmaceuticals Inc Com (NASDAQ:AERI) stake by 265,684 shares to 117,434 valued at $4.45 million in 2016Q4. Pinebridge Invests Limited Partnership has invested 0% of its portfolio in Diplomat Pharmacy Inc (NYSE:DPLO). Diplomat Pharmacy had 22 analyst reports since August 4, 2015 according to SRatingsIntel.

11/03/2016 - Diplomat Pharmacy, Inc. was downgraded to "market perform" by analysts at Avondale Partners. Wealthtrust holds 0% or 171 shares in its portfolio. (NASDAQ:AAPL) for 3.19M shares.

D'autres rapports CampDesrEcrues

Discuter de cet article